| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/26/2007 | WO2007082956A1 Thiazole derivatives and use thereof |
| 07/26/2007 | WO2007082946A1 Solid forms of a pyrrolopyrimidine derivative and their use as anti-tumor agents |
| 07/26/2007 | WO2007082935A1 Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts |
| 07/26/2007 | WO2007082922A2 Long term treatment of hiv- infection with tcm278 |
| 07/26/2007 | WO2007082914A2 Method of diagnosis and method of treatment |
| 07/26/2007 | WO2007082910A1 Dicarbonylic compounds with antibacterial activity |
| 07/26/2007 | WO2007082909A2 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 07/26/2007 | WO2007082907A1 Substituted 4-phenylpiperidines |
| 07/26/2007 | WO2007082899A1 Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration |
| 07/26/2007 | WO2007082882A1 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082880A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082878A1 Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082876A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082874A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082873A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082866A2 Use of chavicol for the treatment of superfinfected oily skin and scalp |
| 07/26/2007 | WO2007082864A2 Use of chavicol as an antiseptic |
| 07/26/2007 | WO2007082840A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | WO2007082822A1 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 07/26/2007 | WO2007082809A1 Pharmaceutical composition and process |
| 07/26/2007 | WO2007082806A1 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer’s disease via gaba receptors |
| 07/26/2007 | WO2007082805A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors |
| 07/26/2007 | WO2007082780A1 Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases |
| 07/26/2007 | WO2007082770A1 Coated formulations |
| 07/26/2007 | WO2007082764A1 Pharmaceutical composition comprising amorphous atorvastatin |
| 07/26/2007 | WO2007082698A1 Foam-forming composition |
| 07/26/2007 | WO2007082666A1 Acylaminoimidazoles |
| 07/26/2007 | WO2007082561A2 Method for the treatment of tinnitus |
| 07/26/2007 | WO2007082554A1 Modulators of hcv replication |
| 07/26/2007 | WO2007082546A1 Use of tofisopam as a pde10a inhibitor |
| 07/26/2007 | WO2007082542A1 Compositions comprising oxaprozin and a vitamin d3 analogue and their use for the manufacture of a medicament for the treatment of psoriasis |
| 07/26/2007 | WO2007082475A1 Novel ent-kaurene diterpene compound and its derivatives, their preparation and their use |
| 07/26/2007 | WO2007082472A1 Anti-infective quinolone compound, preparation method thereof and use thereof |
| 07/26/2007 | WO2007082471A1 Anti-infective compound, preparation method thereof and use thereof |
| 07/26/2007 | WO2007082470A1 Pyrrolo-pyridazine derivatives,their preparation methods and uses |
| 07/26/2007 | WO2007082434A1 Quinazoline derivatives,preparation methods and uses thereof |
| 07/26/2007 | WO2007082381A1 Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disorders |
| 07/26/2007 | WO2007082331A1 Modified macromolecule |
| 07/26/2007 | WO2007071393A3 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 07/26/2007 | WO2007068885A3 Active wound dressing materials |
| 07/26/2007 | WO2007067781A3 9-membered heterobicyclic compounds as inhibitors of protein kinases |
| 07/26/2007 | WO2007067478A3 P38 kinase inhibiting agents |
| 07/26/2007 | WO2007066355B1 Processes for the preparation and estimation of enriched calcitriol containing extracts from cestrum diurnum and compositions thereof |
| 07/26/2007 | WO2007065942A3 Bis-heterocyclic imidazolyl compounds |
| 07/26/2007 | WO2007065231A3 Azacytosine derivatives useful as antiviral agents |
| 07/26/2007 | WO2007065007A3 Treatment of viral infections |
| 07/26/2007 | WO2007064993A3 Bicyclic protein kinase inhibitors |
| 07/26/2007 | WO2007064945A3 Cancer therapies and pharmaceutical compositions used therein |
| 07/26/2007 | WO2007062999A3 1,5-substituted indol-2-yl amide derivatives |
| 07/26/2007 | WO2007062175A3 Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| 07/26/2007 | WO2007062167A9 Method of modulating stress-activated protein kinase system |
| 07/26/2007 | WO2007061360A3 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 07/26/2007 | WO2007059421A3 Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same |
| 07/26/2007 | WO2007059116A3 Geldanamycin derivatives and pharmaceutical compositions thereof |
| 07/26/2007 | WO2007058971A3 Soft anticholinergic esters |
| 07/26/2007 | WO2007058634B1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 07/26/2007 | WO2007057756A3 Isocystene derivatives for the treatment of pain |
| 07/26/2007 | WO2007056466A3 Immunosuppression compound and treatment method |
| 07/26/2007 | WO2007056124A3 Compounds for modulating trpv3 function |
| 07/26/2007 | WO2007056087A8 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 07/26/2007 | WO2007054292A3 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 07/26/2007 | WO2007053495A3 Compounds useful as antagonists of ccr2 |
| 07/26/2007 | WO2007052307A3 Stable solid oral dosage forms of valsartan |
| 07/26/2007 | WO2007052295A3 Aqueous anaesthetic compositions comprising propofol |
| 07/26/2007 | WO2007051836A3 Compositions for treating dermatological and neurological disorders |
| 07/26/2007 | WO2007051045A3 Compositions and methods for inhibiting expression of huntingtin gene |
| 07/26/2007 | WO2007049304A3 Stable coated pharmaceutical formulation of olanzapine and process for preparing the same |
| 07/26/2007 | WO2007047492A3 Increasing thymic output in hiv-negative patients with antiretrovirals |
| 07/26/2007 | WO2007046113A3 Novel pharmaceutical composition comprising alkaloid and process thereof |
| 07/26/2007 | WO2007046087A3 Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions |
| 07/26/2007 | WO2007044441A3 Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 07/26/2007 | WO2007042983A3 Fluridone as an anti-inflammatory agent |
| 07/26/2007 | WO2007041241A3 Compositions and methods for detecting ligand-receptor interactions |
| 07/26/2007 | WO2007040650A9 Apoptosis promoters |
| 07/26/2007 | WO2007039569A3 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof |
| 07/26/2007 | WO2007038596A3 Phytosterol nutritional supplements |
| 07/26/2007 | WO2007038110A3 Trans-lutein xantophyllester of high purity and bioavailability in micellar solution |
| 07/26/2007 | WO2007037850A3 Enhanced delivery of cells |
| 07/26/2007 | WO2007033374A3 Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor |
| 07/26/2007 | WO2007032019B1 Process for preparing valsartan |
| 07/26/2007 | WO2007031777A3 Method of determining damage to skin |
| 07/26/2007 | WO2007029124A3 Formulations containing pantoprazole free acid and its salts |
| 07/26/2007 | WO2007025798A3 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 07/26/2007 | WO2007025780A3 Aldosterone receptor antagonists |
| 07/26/2007 | WO2007025142A3 Gel compositions comprising a combination of an antiseptic and an anesthetic agent for treating surface areas in medical and surgical procedures |
| 07/26/2007 | WO2007022501A3 Useful indole compounds |
| 07/26/2007 | WO2007017762A3 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
| 07/26/2007 | WO2007017146A3 Use of collismycin and derivatives thereof as oxidative stress inhibitors |
| 07/26/2007 | WO2007009201A3 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis |
| 07/26/2007 | WO2007008541A3 Cellular cholesterol absorption modifiers |
| 07/26/2007 | WO2007006497A3 Solubilsation products of an active ingredient extract |
| 07/26/2007 | WO2007005644A3 Novel aryloxypropanamines |
| 07/26/2007 | WO2007003948A3 Core 2 glcnac-t inhibitors |
| 07/26/2007 | WO2007002854A3 Inducing peripheral blood vessel vasodilation |
| 07/26/2007 | WO2006138118A3 Anti-viral compositions comprising heterocyclic substituted phenyl furans and related compounds |
| 07/26/2007 | WO2006133954A3 Diclofenac formulations and methods of use |
| 07/26/2007 | WO2006133375A3 Dinucleoside polyphosphate inhibitors of reverse transcriptase |
| 07/26/2007 | WO2006133046A3 Nanoparticulate imatinib mesylate formulations |
| 07/26/2007 | WO2006132947A3 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof |
| 07/26/2007 | WO2006127810A3 Bacterial cellulose-containing formulations and method of producing effective bacterial cellulose-containing formulations |